Invacare Corporation announces that it has appointed Barbara Bodem to its Board of Directors.
Bodem currently serves as senior vice president of finance for Mallinckrodt plc, a global specialty pharmaceutical company.
She previously served as vice president, global commercial finance for Hospira, and chief financial officer for the Lilly Oncology Business. She received her BS and MBA degrees from Indiana University.
“We are excited to welcome Barbara to the Invacare Board of Directors. Barbara is an accomplished business leader with outstanding experience at global pharmaceutical and medical device companies, which will enable her to provide insight and counsel to our company and fellow Board members,” said Matthew E. Monaghan, chairman, president and chief executive officer of Invacare, in a media release.
“I am excited to join the Invacare Board of Directors and to be part of the next phase of the company’s transformation and growth. I look forward to working with Matt Monaghan, Dr Martin Harris, lead director, and my talented colleagues on the Board, to realize Invacare’s strategic vision,” Bodem states in the release.
[Source(s): Invacare Corporation, Business Wire]
